INFECTIOUS DISEASES: TUBERCULOSIS, PNEUMONIA, UTI, HEPATITIS, GONORRHOEA, SYPHILIS, MALARIA, HIV, AND SARS-CoV-2: A TEACHER’S COMPREHENSIVE GUIDE
Welcome, future pharmacists and healthcare professionals!
Infectious diseases are conditions caused by bacteria, viruses, fungi, and parasites. The human body is home to a wide variety of organisms—usually they are not harmful or even beneficial. But some organisms in specific situations have the potential to cause illness. As a pharmacy educator with years of experience teaching pharmacotherapeutics, I have observed that students often find infectious diseases challenging due to the vast number of pathogens, their complex life cycles, and the pharmacological management involved. Let me tell you: Understanding infectious diseases is essential for every pharmacy professional.
In this comprehensive guide, I will walk you through the major infectious diseases—Tuberculosis, Pneumonia, Urinary Tract Infection, Hepatitis, Gonorrhoea, Syphilis, Malaria, HIV, and SARS-CoV-2. I will explain their types, etiology, pathogenesis, clinical manifestations, and both non-pharmacological and pharmacological management. By the end of this article, you will have a thorough understanding of these critical conditions. Let us begin our journey!
Dpharmguru’s exam insights:
Infectious diseases are frequently tested in pharmacy exams. Remember: Tuberculosis is caused by Mycobacterium tuberculosis. Pneumonia can be bacterial, viral, or fungal. UTI is commonly caused by E. coli. Hepatitis has five types—A, B, C, D, and E. Gonorrhoea and Syphilis are sexually transmitted infections. Malaria is caused by Plasmodium parasites. HIV causes AIDS. SARS-CoV-2 causes COVID-19. Pay special attention to the pharmacological management of each condition—these are almost always asked in exams!
1. TUBERCULOSIS (TB)
Tuberculosis is an infectious disease caused by the bacterium Mycobacterium tuberculosis. It is a communicable disease which spreads from patient to other healthy persons. TB typically affects the lungs and also affects other organs and bones. The bacteria that cause TB are spread from person to person by tiny droplets released into the air via cough and sneezing.
Types of TB
- Primary Tuberculosis: Highly infectious type associated with pneumonia. Most commonly affects aged ones, very young children, and patients with weak immunity.
- Tuberculosis Pleurisy: Seen shortly after first infection; characterized by rupturing of granuloma into the pleural space.
- Cavitary TB: Destruction in lungs progresses, forming cavities. Upper lobes are adversely affected as M. tuberculosis grows rapidly in oxygen-rich environment.
- Miliary TB: Tiny nodules (like millet seeds) appear all over the lungs. Can manifest as acute form (high fever, fatal) or chronic form (declines slowly).
- Laryngeal TB: Highly infectious type which infects the larynx or vocal cord area.
- Extra-Pulmonary Tuberculosis (EPTB): TB that originates in the body but does not spread to the lungs. Can affect genitourinary tract, gastrointestinal tract, meninges, lymph nodes, bones, and joints.
Etiology of TB
- Droplet Infection: Transmission occurs by inhalation of oral droplets released by an infected person
- Intake of Unpasteurised Cow Milk: TB may be caused by M. bovis present in unpasteurised milk
- Re-Infection: The degree of protection provided by primary infection is limited
- Diseased Conditions: Diabetes, alcoholism, liver cirrhosis, congenital heart diseases, whooping cough, influenza decrease body resistance
- Socio-economic Factors: Malnutrition makes individuals unable to resist infections
Pathogenesis of TB
Primary or TB Infection:
- Microorganisms enter the lungs and are engulfed by macrophages
- Local inflammation occurs on the periphery of the upper lobes of lungs
- Macrophages and lymphocytes cluster into a granuloma containing bacilli, forming a tubercle
- Caseation necrosis develops in the centre of the tubercle
- Ghon complexes are lesions of lung and lymph nodes
- The calcified tubercle can be seen in chest radiograph
- After 6–8 weeks, the complete immune response is completed—known as latent infection
Secondary or TB Infection:
- Active infection that may arise after years of primary infection
- M. tuberculosis survives in tubercles and becomes reactive if host resistance decreases
- New invasion of microbes, tissue destruction, and necrosis of large area occurs
- Large open area in the lungs and erosion of bronchi and blood vessels results in cavitation
Clinical Manifestations of TB
- Coughing (lasts longer than 2 weeks with green, yellow, or bloody sputum)
- Weight loss
- Fatigue or malaise
- Fever
- Night sweats
- Chills
- Anorexia
- Chest pain
- Shortness of breath
- Loss of appetite
Non-Pharmacological Management of TB
- Medical personnel must wear highly efficient disposable masks
- Patients suspected of having TB should be kept in a separate room
- Proper instructions on good cough hygiene
- Supplements with vitamins and minerals
- Comprehensive nutritional assessment, counseling, and support
- Rest, proper nutrition, and hygiene maintenance
Pharmacological Management of TB
DOTS (Directly Observed Therapy): Recommended by WHO. Healthcare workers observe the administration of each drug dose.
First-line Drugs: Streptomycin sulphate, Rifampicin, Isoniazid, Ethambutol, Pyrazinamide, Thiacetazone
Second-line Drugs: Para Amino Salicylic (PAS) acid, Ethionamide, Cycloserine, Viomycin, Capryomycin, Kanamycin
Dpharmguru’s exam insights:
TB management is frequently tested. Remember: DOTS is the WHO-recommended strategy. First-line drugs are used initially; second-line drugs are used when bacilli become resistant. A common exam question is: “What is the first-line drug for TB?” (Answer: Isoniazid, Rifampicin, Ethambutol, Pyrazinamide).
2. PNEUMONIA
Pneumonia is an infection caused by bacteria, viruses, or fungus in one or both lungs. Infected lungs can cause swelling of the airways and accumulation of mucus and fluids in the air sacs of lungs.
Types of Pneumonia
- Lobar Pneumonia: Affects one or more lobes of the lungs
- Bronchial Pneumonia (Bronchopneumonia): Affects patches throughout both lungs
- Hospital-Acquired Pneumonia (HAP): Contracted in the hospital; bacteria may be more resistant to drugs
- Community-Acquired Pneumonia (CAP): Acquired outside a medical or institutional setting
- Ventilator-Associated Pneumonia (VAP): Affects patients who use a ventilator
- Aspiration Pneumonia: Caused by inhaling microorganisms from food, drink, or saliva into the lungs
Etiology of Pneumonia
- Bacteria: Streptococcus pneumoniae (most prevalent)
- Mycoplasma pneumoniae and Other Atypical Bacteria: Mycoplasma pneumoniae, Chlamydia pneumoniae, Legionella pneumoniae
- Viruses: Any virus that causes a respiratory tract infection (colds and flu)
- Fungi (Molds): Least prevalent; e.g., Valley fever
Pathogenesis of Pneumonia
- Infectious organisms bypass host’s physical defences
- Macrophages may be overcome, leading to creation of a fibrin-rich exudate
- Neutrophils proliferate, harming lung tissue, resulting in fibrosis and pulmonary oedema
- Inflammatory reaction can result in pleural effusion
- Gaseous exchange is diminished
Clinical Manifestations of Pneumonia
- Lips and fingernails turn bluish
- Confused mental state or delirium (especially in older people)
- Cough that produces green, yellow, or bloody mucus
- Fever
- Excessive sweating
- Loss of appetite
- Tiredness and lack of energy
- Excessive breathing
- Rapid heartbeat
- Chills
Non-Pharmacological Management of Pneumonia
- Oxygen therapy
- Ventilatory support
- Physiotherapy
Pharmacological Management of Pneumonia
- Macrolides: Azithromycin, Clarithromycin, Erythromycin
- Hydration: Important as fever and tachypnea can cause fluid loss
- Antipyretics: Aspirin, Ibuprofen, Naproxen, Acetaminophen
- Bed Rest: Until signs of infection have faded
- Oxygen Administration: In case hypoxemia develops
- Pulse Oximetry: To assess need for oxygen and therapy effectiveness
- Aggressive Respiratory Measures: High-oxygen administration, endotracheal intubation, mechanical ventilation
3. URINARY TRACT INFECTIONS (UTI)
Urinary Tract Infection is a symptomatic bacterial infection of the urinary tract. It includes lower urinary tract infection (cystitis, urethritis, prostatitis) or upper urinary tract infection (pyelonephritis).
Types of UTI
- Based on Clinical Features:
- Complicated UTI: Associated with underlying conditions (pregnancy, diabetes, immunosuppression, structural abnormalities)
- Acute Uncomplicated UTI: Occurs in healthy individuals with no abnormalities
- Based on Anatomical Site:
- Cystitis: Infection in urinary bladder
- Urethritis: Infection of urethra
- Pyelonephritis: Infection spreading to kidney
- Prostatitis: Infection of prostate gland
- Based on Occurrence:
- Relapsed UTI: Persists with original organism without complete clearance
- Recurrent UTI: Occurs after successful treatment
Etiology of UTI
- Inability or failure to empty the bladder completely
- Instrumentation of the urinary tract (catheterisation, cystoscopy)
- Obstructed urinary flow
- Decreased natural host defenses
Clinical Manifestations of UTI
- Pain in the side (flank), abdomen or pelvic area
- Pressure in the lower pelvis
- Frequent need to urinate (frequency), urgent need (urgency), incontinence
- Painful urination (dysuria) and blood in urine
- Need to urinate at night
- Abnormal urine colour (cloudy urine) and strong or foul-smelling urine
Pharmacological Management of UTI
Drugs: Trimethoprim, Sulfamethoxazole, Fosfomycin, Nitrofurantoin, Cephalexin, Ceftriaxone, Ofloxacin, Ciprofloxacin, Norfloxacin, Amoxicillin
4. HEPATITIS
Hepatitis is a condition of liver inflammation as a result of an injury or infection. The most common cause is the hepatitis virus (viral hepatitis). However, it may also be caused by other infections, toxic substances (alcohol, certain drugs), and autoimmune diseases.
Types of Viral Hepatitis
| Parameter | Hepatitis A | Hepatitis B | Hepatitis C |
|---|---|---|---|
| Other Name | Infectious hepatitis | Serum/transfusion hepatitis | Non-A, Non-B hepatitis |
| Causative Organism | HAV | HBV | HCV |
| Transmission | Faecal–oral route | Parenteral, sexual contact | Parenteral, close contact |
| Prevention | Vaccination, good hygiene | Vaccination, safe sex | No vaccine available |
Hepatitis A
Etiology: Caused by HAV virus, transmitted via faecal–oral route or by consuming contaminated food or water. Self-limiting disease.
Clinical Manifestations: Fatigue, sudden nausea and vomiting, pain on upper right side of abdomen, clay-coloured stool, loss of appetite, mild fever, dark-coloured urine, joint pain, jaundice, intense itching
Hepatitis B
Etiology: Caused by HBV. Chronic infection lasts for 6 months or more. Affects infants and children more severely.
Transmission: Contaminated needles, sexual contact, mother to infant, close contact, blood transfusion, hospital exposure
Clinical Manifestations: Abdominal pain, dark-coloured urine, fever, joint pain, loss of appetite, nausea and vomiting, weakness and fatigue, jaundice
Pharmacological Management: Entecavir, Telbivudine, Tenofovir alafenamide, Tenofovir disoproxil fumarate, Interferon alfa-2b, Peginterferon alfa-2a
5. GONORRHOEA
Gonorrhoea is a sexually transmitted disease caused by Neisseria gonorrhoeae (a Gram-negative diplococcus bacterium) and most commonly affects the genitourinary tract.
Clinical Manifestations
In Females: Increased vaginal discharge, dysuria, disturbed menstrual cycle, vaginal bleeding after sexual activity
In Males: Dysuria, urethral discharge (yellowish-white), rectal pain, itching, constipation
Pharmacological Management of Gonorrhoea
Adults & Youth ≥ 9 Years: Ceftriaxone (250 mg IM) + Azithromycin (1 g oral) as preferred treatment.
Children (< 9 Years): Cefixime (8 mg/kg BID × 2 doses) + Azithromycin (20 mg/kg) OR Ceftriaxone (50 mg/kg IM) + Azithromycin.
6. SYPHILIS
Syphilis is a sexually transmitted disease caused by the bacterium Treponema pallidum.
Types of Syphilis
- Congenital Syphilis: Transmitted from infected mother to infant
- Acquired Syphilis: Transmitted through sexual contact or infected blood
Stages of Syphilis
- Primary Stage: Ulcer or chancre at site of infection
- Secondary Stage: Skin rashes, condylomata lata, mucocutaneous lesions, generalized lymphadenopathy
- Early Latent Stage: Infection of less than 2 years
- Late Syphilis: Gummatous, neurological, and cardiovascular syphilis
Pharmacological Management of Syphilis
Early Syphilis: Benzathine benzylpenicillin (2.4 million IU) IM single dose
Late Latent Syphilis: Benzathine benzylpenicillin (2.4 million IU) IM once weekly for 3 weeks
7. MALARIA
Malaria is a life-threatening disease transmitted through the bite of an infected female Anopheles mosquito carrying the Plasmodium parasite.
Etiology
Causative agents: P. falciparum (most deadly), P. vivax (most common), P. ovale, P. malariae, P. knowlesi, P. semiovale
Clinical Manifestations of Malaria
- High fever (comes and goes; pattern depends on species)
- Flu-like symptoms with high fever, fatigue, body aches
- Headache, nausea, shaking chills (rigors), sweating, weakness
- Anaemia (due to attack on RBCs)
- Haemolytic anaemia, yellow skin discolouration, kidney failure, pulmonary oedema, cerebral malaria, convulsions, coma, death
Pharmacological Management of Malaria
Drugs: Artemisinin (artemether, artesunate), Atovaquone, Chloroquine, Doxycycline, Mefloquine, Quinine
8. HIV
AIDS (Acquired Immunodeficiency Syndrome) is a condition characterized by a group of signs and symptoms occurring together as a result of decreased efficiency of the immune system, caused by HIV.
Etiology
- HIV-1: Most common worldwide
- HIV-2: Most common in West Central Africa, parts of Europe, and India
Clinical Manifestations of HIV
- Pulmonary Infection: Pneumocystis pneumonia, tuberculosis, tumours
- Skin Disease: Tumour
- Neurological and Psychiatric Involvement: Encephalitis, meningitis
- Gastrointestinal Infection: Esophagitis, chronic diarrhoea, tumours
Pharmacological Management of HIV
First-line ART: Zidovudine (AZT) + Lamivudine (3TC) + Nevirapine (NVP) OR Stavudine (d4T) + Lamivudine (3TC) + Nevirapine (NVP)
Alternative Regimens: AZT + 3TC + Efavirenz (EFV) OR d4T + 3TC + EFV
9. VIRAL INFECTION – SARS-CoV-2
COVID-19 is caused by a novel coronavirus called Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
Clinical Manifestations of SARS-CoV-2
Most Common Symptoms: Fever, Dry cough, Tiredness
Less Common Symptoms: Aches and pains, Sore throat, Diarrhoea, Conjunctivitis, Headache, Loss of taste or smell, Rash on skin, Discolouration of fingers or toes
Serious Symptoms: Difficulty in breathing or shortness of breath, Chest pain or pressure, Loss of speech or movement
Pharmacological Management of SARS-CoV-2
Drugs: Paxlovid (Nirmatrelvir + Ritonavir), Remdesivir (Veklury), Bebtelovimab, Molnupiravir (Lagevrio)
FREQUENTLY ASKED QUESTIONS (FAQs)
1. What is the difference between bacterial and viral pneumonia?
Bacterial pneumonia is caused by bacteria (e.g., Streptococcus pneumoniae) and can be treated with antibiotics. Viral pneumonia is caused by viruses (e.g., influenza) and is treated with supportive care and antiviral drugs.
2. What is the difference between Hepatitis A, B, and C?
Hepatitis A is transmitted via the faecal–oral route and is self-limiting. Hepatitis B and C are transmitted via blood and body fluids; Hepatitis B has a vaccine, Hepatitis C does not.
3. What is the DOTS strategy for TB?
DOTS (Directly Observed Therapy) is a WHO-recommended strategy where healthcare workers observe the administration of each drug dose to ensure patient compliance and prevent drug resistance.
4. What is the difference between HIV and AIDS?
HIV is the virus that causes infection. AIDS is the most advanced stage of HIV infection, characterized by a CD4 count below 200 cells/mm³ or the presence of opportunistic infections.
5. What is the recommended treatment for uncomplicated gonorrhoea?
The recommended treatment is Ceftriaxone (250 mg IM) + Azithromycin (1 g oral) in a single dose.
6. What are the first-line drugs for malaria?
First-line drugs for malaria include Artemisinin derivatives (artemether, artesunate), Chloroquine, and combination therapies.
SUMMARY
Infectious diseases are among the most common conditions affecting people worldwide. This guide covered the major infectious diseases:
- Tuberculosis: Caused by Mycobacterium tuberculosis; treated with DOTS therapy using first-line drugs
- Pneumonia: Caused by bacteria, viruses, or fungi; treated with antibiotics, antivirals, or supportive care
- UTI: Bacterial infection of urinary tract; treated with antibiotics
- Hepatitis: Liver inflammation caused by HAV, HBV, HCV; prevention through vaccination (A, B) and hygiene
- Gonorrhoea: STI caused by Neisseria gonorrhoeae; treated with Ceftriaxone + Azithromycin
- Syphilis: STI caused by Treponema pallidum; treated with Benzathine penicillin
- Malaria: Parasitic infection transmitted by Anopheles mosquito; treated with Artemisinin derivatives
- HIV: Viral infection causing AIDS; treated with ART (combination therapy)
- SARS-CoV-2: Viral infection causing COVID-19; treated with antiviral drugs and supportive care
As I always tell my students: “Infectious diseases remain a major global health challenge. Understanding their pathogenesis and pharmacological management is essential for saving lives and improving public health.”
REFERENCES AND FURTHER READING
- Pharmacy Council of India (PCI). (2022). Pharmacotherapeutics Syllabus. New Delhi: PCI.
- Rang, H. P., & Dale, M. M. (2021). Rang & Dale’s Pharmacology (9th ed.). Elsevier.
- Goodman, L. S., & Gilman, A. (2018). Goodman & Gilman’s The Pharmacological Basis of Therapeutics (13th ed.). McGraw-Hill.
- Katzung, B. G. (2021). Basic and Clinical Pharmacology (15th ed.). McGraw-Hill.
- World Health Organization (WHO). (2022). Infectious Diseases. Retrieved from https://www.who.int.
- Centers for Disease Control and Prevention (CDC). (2023). Sexually Transmitted Infections Treatment Guidelines.
- National Institute for Health and Care Excellence (NICE). (2023). COVID-19 Treatment Guidelines.
Disclaimer: This article is for educational purposes only and does not constitute medical advice. Always consult qualified healthcare professionals for medical concerns. Pharmaceutical regulations and guidelines may vary by region—always refer to your local regulatory authorities for specific requirements.
written by:
Dr. N. Sujith Kumar
For More Study Materials, Visit: www.dpharmguru.com
